Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 42571-432

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 42571-432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexa-crtn.jpg (Dexa Crtn)

This is a description of dexamethasone sodium phosphate injection, USP, which contains 10 mg per mL of Dexamethasone. It is a sterile solution for intravenous or intramuscular use only. The medication is preservative-free and comes in 251 mL single-dose vials. The usual dosage and storage instructions are provided on the packaging insert. The manufacturer indicated is Micro Labs Limited from Bangalore, India. The pH of the solution is adjusted with citric acid monohydrate or sodium hydroxide, and it should be protected from light. The container closure is not made with natural rubber latex. Please note that the expiry date for this version is July 2022.*

FDA Label Image

Dexa-lbl.jpg (Dexa Lbl)

This is a product label for Dexamethasone Sodium Phosphate Injection, USP at a concentration of 10 mg per mL intended for intravenous or intramuscular use only. It is preservative-free and comes in a 1 mL single-dose vial. The product should be protected from light and any unused portion should be discarded. The product is manufactured for Micro Labs USA, Inc. located in Somerset, NJ 08873. The information on the label includes a unique code and a revision date of 03/2023.*

FDA Label Image

Dexa-str.jpg (Dexa Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.